LEXINGTON, Mass.--(BUSINESS WIRE)--Cubist Pharmaceuticals, Inc. (NASDAQ: CBST) today announced that Steven C. Gilman, Ph.D., has been promoted to Executive Vice President, Research and Development and Chief Scientific Officer. Dr. Gilman joined Cubist in 2008 as Senior Vice President, Discovery and Non-clinical Development and Chief Scientific Officer.
